Fig. 6From: Evaluation of models to predict prognosis in patients with advanced hepatocellular carcinoma treated with TACE combined with apatinibTime-dependent receiver operating characteristic analyses of HAP score, Six-and-twelve score, Up-to-7 criterion and ALBI grade for 6-month (A), 12-month (B) and 24-month (C) survivalBack to article page